T he risk of developing cardiovascular disease is lower in young women when compared with similarly aged men. [1] [2] [3] However, pregnancy represents a period of increased susceptibility to disordered cardiovascular regulation for women. Pregnant women have an elevated risk for orthostatic intolerance. 4, 5 Moreover, ≤8% of pregnancies are associated with the development of de novo hypertension. 6 The cause of such hypertensive pregnancy disorders remains unclear, and as a result, there exist few approaches by which clinicians can predict, screen, or treat the development of the hypertensive disorders of pregnancy (gestational hypertension and preeclampsia). Previous data have shown that the vascular response to the cold pressor test (CPT) is blunted in normal pregnant women compared with women in the nonpregnant, postpartum state. 8 However, an elevated pressor response to the CPT has been observed in women with 9 or who subsequently develop 10 preeclampsia. As such, the CPT has been suggested as a simple screening tool for pregnancy-related hypertensive disorders. The mechanisms driving these divergent responses remain unknown; however, sympathetic nervous system activity is a primary determinant of the pressor response to the CPT.
pregnancy is associated with elevations in muscle sympathetic nerve activity, 4, 13, 14 which occur progressively across the trimesters of pregnancy. 15 This increase in baseline sympathetic activity occurs concomitantly with elevations in circulating nitric oxide and reductions in vascular resistance. 16, 17 As a result, neurovascular transduction is reduced in normotensive pregnancy. 4 Moreover, the vascular changes more than offset the increase in sympathetic activity because mean arterial pressure (MAP) is reduced in the first and second trimesters until a return toward prepregnancy blood pressures in the third trimester. [18] [19] [20] However, it remains unclear whether sympathetic responsiveness or neurovascular transduction is altered during the CPT in normal pregnancy.
Therefore, the purpose of this study was to compare sympathetic responsiveness during the CPT and quantify the resultant hemodynamic outcomes between normotensive pregnant women and nonpregnant controls. We hypothesized that sympathetic responses to CPT would be exacerbated in pregnant women, indicating increased sympathetic reactivity. We further hypothesized that neurovascular transduction would be blunted in pregnant women, resulting in no differences in hemodynamic outcomes between pregnant and nonpregnant women.
Methods Participants
Eighteen pregnant and 16 nonpregnant women (Table 1 ) participated in the research study after providing written, informed consent. All participants were normotensive nonsmokers and free of respiratory, cardiovascular, and neurological diseases. All pregnant women had singleton pregnancies and were tested in the third trimester (range, 29-40 weeks' gestation; mean, 33±4 weeks). None of the participants reported a history of gestational diabetes mellitus, gestational hypertension, or preeclampsia. Postpartum follow-up with all pregnant women (maternal recall) confirmed that none of the participants developed these conditions during their pregnancy. All nonpregnant women were white, and all pregnant women except 2 Asian women were white. Nonpregnant women were tested during the early follicular phase of the menstrual cycle, with the exception of those taking oral contraceptives (Micronor, n=1; Yaz, n=1) and those using intrauterine devices inhibiting menses altogether (Minera, n=3); these women were tested at their convenience. All test protocols were approved by the Health Research Ethics Board at the University of Alberta and conformed to institutional guidelines and the standards set by the latest revision of the Declaration of Helsinki.
Experimental Protocol
Participants arrived at the laboratory at 8:00 am after a 12-hour fast and having abstained from caffeine, alcohol, and strenuous exercise for 12 hours. Participants were fed a light, standardized meal and were instructed to void their bladder. Participants were seated in a semirecumbent position (sitting with upper body ≈45° from supine) in a dentist-style chair in a laboratory maintained at 20°C. After all instrumentation was complete, participants rested for a minimum of 10 minutes before baseline measures were begun. After 3 minutes of established baseline, the left hand was placed in ice water up to the wrist for 3 minutes.
Instrumentation
Muscle sympathetic nerve activity was assessed using microneurography. 21 Briefly, a tungsten recording electrode with an uninsulated 1 to 5 μm tip was inserted transcutaneously into the peroneal nerve at or distal to the fibular head, and a reference electrode was inserted subcutaneously 1 to 3 cm from the recording site. The recording electrode was manipulated into position within close proximity of sympathetic neurons, which produced pulse-synchronous bursts of activity characteristic of sympathetic vasoconstrictor neurons innervating skeletal muscle. 22 The sympathetic signal was further verified by the presence of increases in firing frequency during voluntary apnea and lack of responsiveness during arousal to a loud noise. 22 The raw sympathetic signal was amplified by a preamplifier (1000×) and then by a variable-gain, isolated amplifier (10 000×; model 662C-3; Iowa University Bioengineering, IA), band-pass-filtered (700-2000 Hz), rectified, and integrated (time constant 0.1 s).
Heart rate was measured using a standard 3-lead ECG. Blood pressure was measured continuously using photoplethysmography (Finometer; Finapres Medical Systems, Amsterdam, The Netherlands) and later calibrated to the average of 3 baseline blood pressure values obtained using manual sphygmomanometry. Manual blood pressures were assessed at the brachial artery just proximal to the elbow (arm straight or in mild elbow flexion) using a mercury sphygmomanometer and a medium-sized blood pressure cuff. All measures were performed by a trained observer. Calibrated pressure waveforms were analyzed to determine beat-by-beat MAP and systolic and diastolic blood pressures. Cardiac output (Q) was assessed using the Modelflow algorithm in the Finometer. Beat-by-beat total peripheral resistance (TPR) was calculated as MAP/Q.
Data Analysis
All data were stored for offline data analysis (PowerLab/16SP with LabChart 7; ADInstruments, Colorado Springs, Colorado). Baseline muscle sympathetic nerve activity signals were obtained in 12 pregnant and 12 nonpregnant participants. Responses to the 3-minute CPT were analyzed in 1-minute bins. In participants in whom adequate sympathetic recordings were maintained during the CPT (n=9 nonpregnant and n=9 pregnant), the 1-minute period corresponding to peak sympathoexcitation was selected for all subsequent analyses. The mode of the peak sympathoexcitatory period was the first minute of CPT in nonpregnant women and the second minute of CPT in pregnant women. However, the mean of the peak sympathoexcitation was not different between nonpregnant (1.6±0.7) and pregnant women (2.1±0.8; P=0.1). Therefore, these bins (1st min in nonpregnant and 2nd min in pregnant women) were selected for analysis of hemodynamics in those participants in whom sympathetic recordings were not obtained.
Bursts of sympathetic activity were identified using semiautomated peak detection and confirmed by a trained observer. Sympathetic activation was quantified as burst frequency (bursts/min) and burst incidence (bursts/100 hb), as well as burst amplitude and total muscle sympathetic nerve activity (amplitude×frequency). Burst amplitude was normalized within each participant by expressing all burst amplitudes relative to the largest burst observed at baseline, which was assigned a value of 100. To compare burst amplitudes at baseline, probability distribution curves were generated, and the median of these distributions were compared between groups.
Basal neurovascular transduction was calculated as TPR/sympathetic burst frequency and MAP/sympathetic burst frequency. In all hemodynamic and sympathetic outcomes, relative responses to CPT were calculated by subtracting baseline values from CPT values. Neurovascular reactivity during CPT was subsequently calculated by dividing the relative changes in TPR and MAP by the relative changes in sympathetic activity. 
Statistical Analyses
Baseline values and peak CPT responses were compared between pregnant and nonpregnant women using Student's unpaired t tests (all 2-tailed). The effects of CPT (ie, across all 1-minute time bins) and group and the interactions between them were examined using 2-way split-plot ANOVA. Alpha was set at 0.05 for all comparisons. Relationships between sympathetic nerve activity and vascular outcomes were assessed using linear regression analyses.
Results

Baseline
Baseline blood pressures were similar between pregnant women and controls (Table 2) . Heart rate and Q were elevated in the pregnant women, whereas TPR was reduced relative to the nonpregnant controls. Sympathetic burst frequency, incidence, and total activity were higher in the pregnant women (Table 3) . However, burst amplitude distribution curves were not different between pregnant and nonpregnant women (Table 3) . Baseline sympathetic neurovascular transduction (TPR/sympathetic burst frequency) was significantly reduced in the pregnant women relative to nonpregnant (Figure 1 ; P<0.001). Similarly, transduction expressed as MAP/sympathetic burst frequency was reduced in pregnant women (2.4±0.7) relative to nonpregnant women (3.6±0.8 mm Hg/ bursts/min; P=0.001).
Responses to the Cold Pressor Test
Hemodynamic and sympathetic responses across 3 minutes of CPT are shown in Figure 2 . All variables were increased significantly across stages of the CPT. Heart rate was higher and TPR was lower across all time points in the pregnant women relative to the nonpregnant participants. A group×CPT interaction was observed in MAP, with pregnant women having lower pressure during the third minute of CPT (P=0.04). However, the relative changes in hemodynamics during the minute of peak sympathetic activation during CPT were similar between groups ( Figure 3 ). Sympathetic burst amplitude did not change during CPT and remained similar between groups (Figure 2 ). Sympathetic burst frequency, incidence, and total activity were higher during CPT in the pregnant women compared with the nonpregnant women. Further, during peak sympathoexcitation, the relative increases in sympathetic burst frequency, incidence, and total activity were also larger in the pregnant women (Figure 3) . Neurovascular transduction was reduced in both pregnant and nonpregnant women during the CPT (Figure 1 ) and remained blunted in the pregnant women relative to the nonpregnant women. In contrast to the difference between groups in neurovascular transduction at rest, neurovascular responsiveness during the CPT, expressed as the change in TPR for a given change in sympathetic activity, was similar between groups (P=0.6; Figure 1 ).
Sympathetic-Hemodynamic Associations
Under baseline conditions, no relationships were observed between sympathetic nerve activity and hemodynamic outcomes in either the pregnant or the nonpregnant women ( Figure 4) . In nonpregnant women, sympathoexcitation in response to CPT was associated with the development of significant, positive relationships between sympathetic burst incidence and both TPR and MAP. In contrast, prevailing sympathetic nerve activity remained unassociated with MAP, Q, or TPR in the pregnant women during CPT.
Discussion
The present study provides direct evidence for heightened sympathoexcitatory responses during pregnancy. Specifically, generalized increases in sympathetic nerve activity evoked through the application of the CPT were greater in pregnant women relative to similarly aged nonpregnant women. However, as at baseline, exaggerated sympathetic activity in the pregnant women was not associated with greater resultant vascular resistance or arterial pressure. Together, these data indicate that although the third trimester of normotensive pregnancy is associated with a pronounced increase in sympathetic reactivity, substantial reductions in neurovascular transduction occur concomitantly, resulting in the dissociation between sympathetic outflow and hemodynamic outcomes in pregnant women.
In the present study, we observed a marked sympathoexcitation in terms of burst frequency, incidence, and total muscle sympathetic nerve activity in normotensive pregnant women under baseline conditions. We also examined the burst amplitude component of the sympathetic signal, but observed no significant pregnancy-induced change in the regulation of baseline burst amplitude. During CPT, the burst frequency component remained elevated from baseline levels in the pregnant women relative to the nonpregnant women. Moreover, despite starting at a relatively higher level of sympathetic nerve activity, the pregnant women exhibited a larger peak increase in sympathetic activity from baseline when compared with the nonpregnant women. Conversely, the increases in burst amplitude which occurred in response to CPT were nearly identical between the pregnant and nonpregnant participants (effect of group, P=0.8). That we observed that pregnancy-related increases in sympathetic activity exist only in the frequency component of the sympathetic signal, and not in the amplitude component, is indicative that sympathetic hyperactivity during pregnancy is because of mechanisms regulating the gating of sympathetic activity and not generalized central sensitization. This hypothesis is in keeping with our recent data demonstrating baroreflex resetting during pregnancy, favoring elevated burst incidence for a given arterial pressure. 23 The present data are in line with most, although not all, 12 previous studies which have indicated that pregnancy is associated with an increase in baseline sympathetic activity. 4, [13] [14] [15] To date, only one previous study has compared muscle sympathetic responses to the CPT between normotensive pregnant women and nonpregnant controls. 12 Although similar responses to CPT were observed between groups, the group of pregnant women studied did not exhibit the marked elevations in baseline sympathetic activity, which have come to be associated with pregnancy 4, [13] [14] [15] ; therefore, these women may not be representative of the general population.
An important observation of this study was that, despite markedly elevated sympathetic activity with pregnancy, we observed a reduction in TPR in the pregnant women relative to the nonpregnant women, reflecting a blunting of neurovascular transduction. In fact, although strong, positive relationships between sympathetic activity and both peripheral resistance and MAP were observed during the CPT in the nonpregnant women, we observed no such relationships in the Hemodynamic and sympathetic responses across 3 min of cold pressor test (CPT). All variables were increased significantly across stages of the CPT. Muscle sympathetic nerve activity (MSNA) and heart rate (HR) were consistently greater, and total peripheral resistance (TPR) was consistently reduced in the pregnant women relative to the nonpregnant controls. Data are mean±standard deviation. *P<0.05, nonpregnant vs pregnant. BF indicates burst frequency; BI, burst incidence; and MAP, mean arterial pressure. Figure 3 . Relative changes from baseline during peak cold pressor test sympathoexcitation. Changes in hemodynamics were not different between pregnant and nonpregnant women, whereas relative increases in muscle sympathetic burst frequency (BF), burst incidence (BI), and total activity were greater in pregnant women. Data are mean±standard deviation. *P<0.05 vs nonpregnant. HR indicates heart rate; MAP, mean arterial pressure; MSNA, muscle sympathetic nerve activity; and TPR, total peripheral resistance.
pregnant women. These changes are likely because of the integration of several factors.
1. Changes in circulating hormone levels may exert a direct, excitatory effect on the sympathetic nervous system. Large increases in estradiol and progesterone and modest increases in testosterone occur during pregnancy. 24 Estradiol-mediated excitatory central neural mechanisms 25, 26 may contribute to the pregnancy-induced sympathoexcitation. Likewise, both progesterone 27 and testosterone 28 have been positively associated with sympathetic nerve activity in nonpregnant women. The magnitude of change in circulating aldosterone has also been positively associated with the increase in baseline sympathetic activity during pregnancy. 4 Therefore, it is likely that circulating hormone levels play a role in the pregnancy-induced sympathetic activation. 2. Current evidence is equivocal about changes in circulating norepinephrine (a primary sympathetic neurotransmitter) in healthy pregnant versus nonpregnant women. 4, 8, [29] [30] [31] However, healthy pregnant women seem to exhibit a blunted increase in systemic vascular resistance in response to infusion of norepinephrine. 32 Therefore, even if circulating norepinephrine is shown to increase with sympathetic nerve activity in pregnancy, it seems that pregnancy is associated with a reduced end organ effect. 3. The positive effects of estradiol on endothelial nitric oxide synthesis are well described. 33, 34 Moreover, in vitro studies suggest that estradiol also acts on vascular smooth muscle to evoke vasodilation. 35, 36 Therefore, direct actions of estradiol on the vasculature would encourage vasodilation in pregnant women relative to nonpregnant women, thereby opposing the vasoconstrictory influence of elevated sympathetic nerve activity and reducing neurovascular transduction. 4 . Changes in β-adrenergic receptor density with pregnancy may also contribute to the blunting of neurovascular transduction. 4 Contrary to α-adrenergic receptors, β-adrenergic receptors mediate vasodilation. Young healthy women seem to exhibit greater β-adrenergic responses relative to individuals with lower circulating estradiol levels (ie, men 37, 38 and postmenopausal women 37 ), indicating a favorable role for estradiol on β-adrenergic receptor densities. Moreover, some of the vasodilation elicited through β-adrenergic receptor activation is nitric oxide-dependent, 39 and in that way, the effects of estradiol may be additive. It is possible that higher β-adrenergic binding in pregnant women would enhance vasodilation and thereby support a decreased basal neurovascular transduction. However, little evidence exists to suggest that this occurs, and in fact, some data suggest that β-adrenergic receptor density may be reduced in pregnancy. 40 The pregnancy-induced change in neurovascular transduction represents a possible mechanism which could potentially contribute to the development of the hypertensive disorders of pregnancy. Although vascular responses to the CPT have been shown previously to be blunted in normotensive pregnancy, 8 an augmented blood pressure response to cold pressor stimulation has been observed in women with preeclampsia. 41 Alongside data which indicate that CPT-mediated increases in sympathetic activation are not different between normotensive and hypertensive pregnancies, 12, 42 this suggests that an elevation in neurovascular transduction occurs during preeclamptic pregnancies. In fact, the magnitude of the pressor response to the CPT, as assessed during the second trimester of pregnancy, has been shown to be predictive of the subsequent development of preeclampsia during the third trimester. 
Perspectives
In this study, we have shown that sympathoexcitatory responses to generalized sympathetic stress are exaggerated in normotensive pregnancy. However, neurovascular transduction is reduced in pregnant women, thereby dissociating sympathetic nerve activity from vascular resistance and arterial pressure during CPT. This uncoupling effect represents a possible mechanism which could become dysregulated during pregnancy and, thereby, contribute to the development of the hypertensive disorders of pregnancy, which constitute ≤8% of all pregnancies. 6 Further research is required to investigate whether neurovascular transduction is, indeed, augmented in the hypertensive disorders of pregnancy and the mechanism(s) by which this occurs. An improved understanding of such sympathetic and vascular regulatory mechanisms may aid in the development of treatments and prevention of the hypertensive disorders of pregnancy.
